These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20375900)

  • 1. Management of dyspnea in interstitial lung disease.
    Ryerson CJ; Collard HR; Pantilat SZ
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):69-75. PubMed ID: 20375900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyspnea in interstitial lung disease.
    Collard HR; Pantilat SZ
    Curr Opin Support Palliat Care; 2008 Jun; 2(2):100-4. PubMed ID: 18685404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and health status in interstitial lung diseases.
    De Vries J; Drent M
    Curr Opin Pulm Med; 2006 Sep; 12(5):354-8. PubMed ID: 16926651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of measures of breathlessness.
    Cullen DL; Rodak B
    Respir Care; 2002 Sep; 47(9):986-93. PubMed ID: 12188932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease.
    Jensen D; Schaeffer MR; Guenette JA
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):237-245. PubMed ID: 30074922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation.
    Jastrzebski D; Gumola A; Gawlik R; Kozielski J
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():139-48. PubMed ID: 17072040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical exercise testing in interstitial lung disease.
    Marciniuk DD; Gallagher CG
    Clin Chest Med; 1994 Jun; 15(2):287-303. PubMed ID: 8088094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary rehabilitation for dyspnea in the palliative-care setting.
    Sachs S; Weinberg RL
    Curr Opin Support Palliat Care; 2009 Jun; 3(2):112-9. PubMed ID: 19381095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rehabilitation in non-COPD: mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease.
    Markovitz GH; Cooper CB
    Chron Respir Dis; 2010; 7(1):47-60. PubMed ID: 19880656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional capacity (dyspnea) and quality of life in patients with chronic obstructive lung disease (COPD): instruments of assessment and methodological aspects].
    Hütter BO; Würtemberger G
    Pneumologie; 1999 Mar; 53(3):133-42. PubMed ID: 10226475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pulmonary rehabilitation in the management of patients with lung cancer.
    Shannon VR
    Curr Opin Pulm Med; 2010 Jul; 16(4):334-9. PubMed ID: 20531082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative care for people with non-malignant lung disease: summary of current evidence and future direction.
    Boland J; Martin J; Wells AU; Ross JR
    Palliat Med; 2013 Oct; 27(9):811-6. PubMed ID: 23838376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung volume reduction surgery for the management of refractory dyspnea in chronic obstructive pulmonary disease.
    Shah AA; D'Amico TA
    Curr Opin Support Palliat Care; 2009 Jun; 3(2):107-11. PubMed ID: 19436210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
    Racz H; Mehta S
    J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
    [No Abstract]   [Full Text] [Related]  

  • 17. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options.
    Holland AE
    Chron Respir Dis; 2010; 7(2):101-11. PubMed ID: 20056733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in interstitial lung disease.
    Polomis D; Runo JR; Meyer KC
    Curr Opin Pulm Med; 2008 Sep; 14(5):462-9. PubMed ID: 18664977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced lung disease: quality of life and role of palliative care.
    Gilbert CR; Smith CM
    Mt Sinai J Med; 2009 Feb; 76(1):63-70. PubMed ID: 19170219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.